BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• ANGLE plc: Result of AGM Location

  ANGLE plc, a world-leading liquid biopsy company, announces that at the Annual General Meeting of the Company held earlier today, all resolutions were duly passed.

  October 31, 2017

   · 

  3 min read
• Business

  Sarepta Therapeutics Signs Exclusive Global Collaboration With Duke University for Gene Editing CRISPR/Cas9 Technology to Develop New Treatments for Duchenne Muscular Dystrophy (DMD)

  The exclusive license option grants Sarepta rights to Duke intellectual property for CRISPR/Cas9.

  October 31, 2017

   · 

  8 min read
• Business

  Vedantra Pharmaceuticals Extends Research Collaboration With Neon Therapeutics to Develop Novel Cancer Immunotherapies

  Under the extended agreement, Vedantra and Neon will continue to build on research exploring the potential benefits of combining Vedantra’s cutting-edge, lymph node targeting amphiphile technology with Neon’s innovative capabilities in neoantigen vaccine research.

  October 31, 2017

   · 

  3 min read
• Drug Development

  Catalyst Pharmaceuticals Completes Enrollment in Second Phase III Trial of Firdapse in Patients With Lambert-Eaton Myasthenic Syndrome

  Top-Line results are expected in early December.

  October 31, 2017

   · 

  5 min read
• Business

  Zogenix to Release Third Quarter 2017 Financial Results and Host Conference Call and Webcast on November 7

  The company will host a corporate update conference call and webcast on Tuesday, November 7, 2017 at 4:30 PM ET.

  October 31, 2017

   · 

  1 min read
• Policy

  Sonoma Pharmaceuticals Receives Brazilian Approvals to Market Multiple Hypochlorous Acid-Based Dermatology Products

  The Brazilian Ministério da Saúde issued regulatory approvals for seven of Sonoma’s non-steroidal and non-antibiotic topical dermatology products.

  October 31, 2017

   · 

  5 min read
• Business

  Protalix BioTherapeutics to Hold Third Quarter 2017 Financial Results and Corporate Update Conference Call on November 8, 2017

  The company will provide a corporate update on Wednesday, November 8, 2017 at 8:30 am ET.

  October 31, 2017

   · 

  2 min read
• Business

  Oxford Immunotec Reports Third Quarter 2017 Financial Results

  Revenue for the third quarter of 2017 was $30.4 million, representing 17% growth over third quarter 2016 revenue of $26.1 million.

  October 31, 2017

   · 

  12 min read
• 

  Drug Development

  Sanofi: Dupilumab Significantly Reduced Steroid Use, Asthma Attacks, and Improved Lung Function in a Phase III Study of People With Severe Steroid-Dependent Asthma

  Dupilumab added to standard therapies significantly reduced the use of maintenance oral corticosteroids (OCS) by 70% on average.

  October 31, 2017

   · 

  18 min read
• Business

  The Comprehensive Cancer Center Innsbruck Joins Caris Life Sciences’ Precision Oncology Alliance As First International Member

  The POA, including CCCI, will leverage Caris’ comprehensive genomic profiling plus (CGP+) tumor profiling service, Caris Molecular Intelligence, to identify therapy options and clinical trial opportunities based on the unique molecular characteristics of a patient’s tumor.

  October 31, 2017

   · 

  5 min read